0001144204-16-074142.txt : 20160105 0001144204-16-074142.hdr.sgml : 20160105 20160105173805 ACCESSION NUMBER: 0001144204-16-074142 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160101 FILED AS OF DATE: 20160105 DATE AS OF CHANGE: 20160105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fortress Biotech, Inc. CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205157386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC DATE OF NAME CHANGE: 20080310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEISS MICHAEL S CENTRAL INDEX KEY: 0001038977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35366 FILM NUMBER: 161324007 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 form476424_20160105053737-.xml X0306 4 2016-01-01 0 0001429260 Fortress Biotech, Inc. FBIO 0001038977 WEISS MICHAEL S C/O FORTRESS BIOTECH, INC. 3 COLUMBUS CIRCLE NEW YORK NY US 10019 1 1 1 0 Exec. VC - Strategic Dev. Common Stock, par value $0.001 2016-01-01 4 A 0 510434 0 A 7448472 D Options to purchase Common Stock 2.1 2023-12-19 Common Stock 30000 30000 D Represents an award of restricted shares of the Issuer's common stock made pursuant to the Fortress Biotech, Inc. Long Term Incentive Plan. One-third of the shares will vest on each of December 19, 2014, 2015 and 2016. /s/ S. Halle Vakani, Attorney-in-Fact 2016-01-05